Total Number of HPV Vaccination Encounters Down During Pandemic
FRIDAY, Sept. 23, 2022 (HealthDay News) — There was an increase in human papillomavirus (HPV) vaccination per encounter for pediatric patients aged 9 to 22 years, despite a decrease in overall encounters associated with the COVID-19 pandemic, accordi…
Learn MoreLas vacunas han reducido las tasas de infección con el VPH en las mujeres jóvenes de EE. UU.
LUNES, 22 de agosto de 2022 (HealthDay News) — En 2006, los médicos comenzaron a recomendar la primera vacuna contra el virus del papiloma humano (VPH), de frecuente transmisión sexual, que tenía el potencial de reducir el riesgo de ciertos tipos de …
Learn MoreHPV Vaccination, Infection Rates Examined in U.S. Women
TUESDAY, Aug. 23, 2022 (HealthDay News) — Human papillomavirus (HPV) vaccination appears to be associated with a reduction in HPV-16/18 infection prevalence among a recent birth cohort of vaccinated and unvaccinated 18- to 26-year-old women, accord…
Learn MoreLos casos avanzados de cáncer de cuello uterino siguen en aumento entre las mujeres de EE. UU.
VIERNES, 19 de agosto de 2022 (HealthDay News) — Una nueva investigación apunta a un enigma en el cáncer de cuello uterino: aunque las tasas de enfermedad en etapa temprana han estado en descenso en Estados Unidos desde que se introdujo la vacuna con…
Learn MoreVaccines Have Slashed Rates of HPV Infection in Young American Women
MONDAY, Aug. 22, 2022 (HealthDay News) — Back in 2006, doctors began recommending the first vaccine for the common sexually transmitted human papillomavirus (HPV), with the shots carrying the potential to lower the risk of certain cancers.Now, a new …
Learn MoreCases of Advanced Cervical Cancer Keep Rising Among U.S. Women
FRIDAY, Aug. 19, 2022 (HealthDay News) — New research points to a conundrum with cervical cancer: While rates of early-stage disease have been dropping in the United States ever since the human papillomavirus (HPV) vaccine was introduced, advanced ca…
Learn MoreAl tratar las lesiones del cuello uterino, añadir la vacuna del VPH podría reducir más el riesgo de cáncer
VIERNES, 5 de agosto de 2022 (HealthDay News) — La mayoría de las personas sexualmente activas contraen el virus del papiloma humano (VPH) en algún momento de sus vidas, y alrededor de un 90 por ciento lo eliminan del cuerpo. Pero algunas mujeres son…
Learn MoreHPV Vaccination May Cut Risk for CIN2+ Recurrence
FRIDAY, Aug. 5, 2022 (HealthDay News) — Human papillomavirus (HPV) vaccination seems to reduce the risk for cervical intraepithelial neoplasia grade 2 or higher (CIN2+) recurrence, according to a review published online Aug. 3 in The BMJ.
Konstan…
Learn MoreWhen Treating Cervical Lesions, Adding HPV Vaccine Could Further Curb Cancer Risk
FRIDAY, Aug. 5, 2022 (HealthDay News) — Most sexually active people will contract the human papillomavirus (HPV) during their lifetimes, and about 90% will clear it from their bodies. But some women are susceptible to the cervical lesions that infect…
Learn More